A nurse is caring for a client who is experiencing acute alcohol withdrawal. The nurse should anticipate administering which of the following medications to the client to facilitate the withdrawal process?

A. Diphenhydramine. Diphenhydramine is a first-generation antihistamine with anticholinergic properties that can increase the risk of central nervous system (CNS) depression when taken with haloperidol. Both drugs can cause sedation, confusion, and impaired coordination, increasing the risk of falls and other complications. Additionally, combining them can worsen extrapyramidal symptoms (EPS) or lead to anticholinergic toxicity, making it an unsafe combination.

B. Docusate sodium. Docusate sodium is a stool softener used to prevent constipation. Haloperidol can cause constipation as a side effect due to its anticholinergic properties, so docusate sodium is safe and may even be beneficial in preventing bowel complications.

C. Ibuprofen. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for pain and inflammation. While it does not have a direct interaction with haloperidol, it should be used with caution in clients with a history of gastrointestinal issues or kidney disease. However, it does not pose a significant risk when taken alongside haloperidol.

D. Glucosamine. Glucosamine is a dietary supplement used to support joint health. It does not interact with haloperidol and does not have sedative or CNS effects. Clients taking haloperidol can safely use glucosamine if needed.

A. The client had a local reaction from a previous immunization. A mild local reaction, such as redness or swelling at the injection site, is not a contraindication to receiving the MMR vaccine. These reactions are common and typically resolve without complications. Only severe allergic reactions, such as anaphylaxis, would warrant withholding the vaccine.

B. The client reports having diarrhea this morning. Mild illnesses, such as diarrhea or the common cold, do not contraindicate vaccination. The MMR vaccine can be safely administered as long as the client does not have a moderate to severe illness with fever. Delaying immunization due to minor illnesses could lead to unnecessary gaps in vaccine coverage.

C. The client is at 9 weeks of gestation. The MMR vaccine is a live attenuated vaccine and is contraindicated during pregnancy due to the theoretical risk of fetal harm. Pregnant individuals should wait until after delivery to receive the vaccine. If a client of childbearing age is vaccinated, they should be advised to avoid pregnancy for at least 4 weeks following immunization to reduce the risk of congenital rubella syndrome.

D. The client reports an allergy to penicillin. A penicillin allergy is not a contraindication for the MMR vaccine. The MMR vaccine does not contain penicillin or related antibiotics. Severe allergic reactions to vaccine components, such as neomycin or gelatin, would be more relevant contraindications. Clients with a penicillin allergy can safely receive the MMR vaccine without concern.